These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7110537)

  • 21. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chloral hydrate, gamma-butyrolactone, and equithesin on the efflux of dopamine and 5-hydroxytryptamine metabolites into cerebroventricular perfusates of rats.
    Nielsen JA; Moore KE
    J Neurochem; 1982 Jul; 39(1):235-8. PubMed ID: 6177832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain.
    Jiang DH; Reches A; Wagner HR; Fahn S
    Neuropharmacology; 1984 Mar; 23(3):295-301. PubMed ID: 6539428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
    Clark D; Hjorth S; Carlsson A
    Eur J Pharmacol; 1984 Oct; 106(1):185-9. PubMed ID: 6099268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of morphine on dopamine metabolism in rat striatum and limbic structures in relation to the activity of dopaminergic neurones.
    Moleman P; van Valkenburg CF; vd Krogt JA
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):208-13. PubMed ID: 6493361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine availability and dopamine synthesis in the striatum: studies with gamma-butyrolactone.
    Sved A; Fernstrom J
    Life Sci; 1981 Aug; 29(7):743-8. PubMed ID: 6792441
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of effect of gamma-butyrolactone on amphetamine-induced decrease in striatal synaptosomal dopamine synthesis.
    Kuczenski R
    J Neurochem; 1978 Jul; 31(1):347-9. PubMed ID: 671029
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG; Uretsky NJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
    [No Abstract]   [Full Text] [Related]  

  • 31. Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats.
    Altar CA; O'Neil S; Marshall JF
    Neuropharmacology; 1984 Mar; 23(3):309-18. PubMed ID: 6427648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of voluntary ethanol consumption in rats by gamma-butyrolactone.
    Fadda F; Argiolas A; Melis MR; De Montis G; Gessa GL
    Life Sci; 1983 Mar; 32(13):1471-7. PubMed ID: 6339856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased 3H-L-quinuclidinyl benzilate binding and muscarine receptor subsensitivity after chronic gamma-butyrolactone treatment.
    Giorgi O; Rubio MC
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(1):14-8. PubMed ID: 7329448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of gamma-butyrolactone on behavior due to dopaminergic drugs.
    Dougherty GG; Ellinwood EH
    Physiol Behav; 1983 Apr; 30(4):607-12. PubMed ID: 6683846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of lergotrile on 3,4-dihydroxyphenylacetic acid (DOPAC) concentration and dopamine turnover in rat brain.
    Fuller RW; Perry KW
    J Neural Transm; 1978; 42(1):23-35. PubMed ID: 641542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal dopamine autoreceptors uninfluenced by chronic administration of antidepressants.
    Holcomb HH; Bannon MJ; Roth RH
    Eur J Pharmacol; 1982 Aug; 82(3-4):173-8. PubMed ID: 6813129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M; Westerink BH
    J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. gamma-Hydroxybutyric acid-induced seizures bear no relation to core temperature.
    Snead OC
    Epilepsia; 1990; 31(3):253-8. PubMed ID: 2344842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.